A biotech company in New Zealand is pioneering a new type of diabetic treatment, using a pig cell transplant in order to help diabetic patients stop injecting insulin to manage their disease.
Living Cell Technologies (LCT), who are based in Auckland, conducted a trial of their procedure in Russia due to restrictions in New Zealand. According to the company, one of the two patients taking part in their Russian trial could potentially be cured of diabetes .
The inventor of the therapy, and the medical director of LCT, Professor Bob Elliot, reportedly commented: “Remarkably, a month after the first dose one patient is currently not dependent on insulin. While it is early days within this patient’s treatment protocol these results are very encouraging.”
He reportedly concluded: “These early stage results have exceeded our expectations.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…